Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Nanjing Frontier Biotechnologies has begun a Phase III...
Bayer HealthCare and Peking University of Beijing will...
Dr. Jonathan Wang is Senior Managing Director of OrbiMed...
Shanxi Taxus Pharma announced plans to take over Cardium...
Shanghai-based PhageLux has received an investment from...
BioLight Israeli Life Sciences Investments reported that...
China announced a new $3.2 billion program to fund...
China is Asia’s number one biopharma cluster,...
Techne will acquire Shanghai PrimeGene Bio-Tech, a...
WuXi PharmaTech and TaiMed Biologics of Taiwan today...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
